Companies: 10,795·Total market cap: $144.5T
Semler Scientific, Inc.

Semler Scientific, Inc.

SMLRNASDAQHealthcare
$20.33
$-1.04(-4.87%)
Market Cap$310745920
P/E Ratio
52W High$65.98
52W Low$14.885
Overview

Semler Scientific, Inc. (SMLR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

smlr · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Semler Scientific, Inc. (SMLR) measures how much investors pay for each dollar of the company's trailing earnings. SMLR's current PE ratio of 6.24x is calculated by dividing its stock price of $20.33 by its TTM earnings per share of $3.26. −73.9% discount vs 5Y avg 23.9x

6.24x
P/E Ratio (TTM)73.9%

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
FY2026 est. EPS $-1.92
Based on 1 analyst
EPS (TTM)
$3.26
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Semler Scientific, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2011 – 2024 · Annual
PE Ratio (TTM)
5Y Avg 23.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 7 fiscal years · Front-end computed
Average
27.5x
7-yr mean
Median
20.5x
7-yr midpoint
Minimum
9.5x
Lowest year
Maximum
52.1x
Highest year
6.2x ← Now
9.5x
Min
Q1 · 25%20.5x
Median
Q3 · 75%52.1x
Max
Historically Low

At 6.24x, SMLR's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.

0th percentileHigher than 0 of 7 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Semler Scientific, Inc.
Semler Scientific, Inc.You
SMLR
$311M6.24x$3.26
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc.
CATX
$226MN/A-$1.40
Delcath Systems, Inc.
Delcath Systems, Inc.
DCTH
$379M134.00x$0.08
NeuroPace, Inc.
NeuroPace, Inc.
NPCE
$532MN/A-$0.66
Owens & Minor, Inc.
Owens & Minor, Inc.
OMI
$207MN/A-$14.24
RxSight, Inc.
RxSight, Inc.
RXST
$204MN/A-$0.95
Senseonics Holdings, Inc.
Senseonics Holdings, Inc.
SENS
$295MN/A-$1.66

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 14 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
9.54x$5.66-34.1%
2023-12-31
FY2023
14.49x$3.06-6.5%
2022-12-31
FY2022
15.50x$2.13-56.7%
2021-12-31
FY2021
35.82x$2.56-18.9%
2020-12-31
FY2020
44.19x$2.13+115.6%
2019-12-31
FY2019
20.50x$2.34-60.7%
2018-12-31
FY2018
52.12x$0.66
2017-12-31
FY2017
$-0.28
2016-12-31
FY2016
$-0.50
2015-12-31
FY2015
$-1.72

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Semler Scientific, Inc. (SMLR) measures how much investors pay for each dollar of the company's trailing earnings. SMLR's current PE ratio of 6.24x is calculated by dividing its stock price of $20.33 by its TTM earnings per share of $3.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $20.33 ÷ $3.26 = 6.24x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SMLR pe ratio · 6 questions

SMLR's current PE ratio is 6.24x as of 2026-06-08, based on a stock price of $20.33 and TTM EPS of $3.26. Data sourced from Financial Modeling Prep via SMLR's SEC 10-K and 10-Q filings.

SMLR PE ratioWhat is SMLR PE ratioCurrent PE ratio of SMLRSMLR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Semler Scientific, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08